Market Cap: $16.97B
Market Cap: $16.97B
Open
$76.01
Prev. Close
$76.01
High
$76.01
Low
$76.01
Hologic, Inc. is a medical technology company focused on designing, producing, and marketing a diverse range of diagnostic tests, medical imaging systems, and surgical solutions.
Hologic, Inc. trades on the NASDAQ Global Select under the ticker HOLX, priced in USD.
Hologic, Inc. has a market capitalisation of $16.97B, based on its latest share price.
HOLX trades at 30.28 times its trailing 12-month earnings.
Over the past 52 weeks HOLX has traded between $51.90 and $76.07.
No. Hologic, Inc. does not currently pay a dividend.
Highly profitable: keeps 18.0% of revenue as net profit.
The analyst consensus rating for HOLX is Hold. Analysts' average 12-month price target of $79.00 implies 4% upside.
Paul Malenchini is the CEO of Hologic, Inc., which is headquartered in Marlborough.
Generated automatically from reported financial data. General information only, not financial advice.
RadNet Expands Health Sector Footprint with Strategic Acquisition of Gleamer RadNet, Inc. reports remarkable financial results for the fourth quarter, illustrating its robust performance and promising…
Hologic's Commitment to Women's Health: Advancements in Diagnostic Technology Hologic, a leader in women's health, continues to innovate and expand its diagnostic capabilities, addressing critical nee…
Hologic Under Scrutiny Amid Proposed Sale to Blackstone and TPG Hologic, Inc. finds itself in the spotlight as investor rights law firm Halper Sadeh LLC initiates an investigation into potential viola…
Hologic Under Investigation Amid Acquisition Discussions A recent investigation by Halper Sadeh LLC, an investor rights law firm, places Hologic, Inc. in the spotlight as it examines potential violati…